Laboratory Corporation of America Holdings (LH)

Return on assets (ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 418,000 661,200 830,700 1,000,400 1,279,100 1,756,000 1,990,500 2,099,300 2,377,300 2,762,600 2,878,700 2,642,900 1,556,100 844,900 -175,700 -216,900 285,900 216,700 852,700 896,100
Total assets US$ in thousands 16,725,100 16,886,000 17,718,700 20,200,000 20,155,100 19,826,000 20,403,100 20,728,400 20,385,400 20,866,500 20,417,100 20,417,100 20,071,700 18,739,600 17,849,100 17,298,400 18,046,400 17,847,800 17,744,400 16,970,800
ROA 2.50% 3.92% 4.69% 4.95% 6.35% 8.86% 9.76% 10.13% 11.66% 13.24% 14.10% 12.94% 7.75% 4.51% -0.98% -1.25% 1.58% 1.21% 4.81% 5.28%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $418,000K ÷ $16,725,100K
= 2.50%

The return on assets (ROA) for Laboratory Corp. Of America Holdings has shown a declining trend over the past eight quarters. In Q4 2022, the ROA was 6.35%, which steadily decreased to 2.50% in Q4 2023. This declining trend indicates that the company's ability to generate profit from its assets has been decreasing over time.

The ROA peaked at 10.13% in Q1 2022, before experiencing a consistent decrease quarter over quarter. This may be a cause for concern, as a declining ROA could signal inefficiencies in asset utilization or a decrease in profitability relative to the company's asset base.

Investors and stakeholders should closely monitor the company's ROA in future quarters to assess whether the trend continues or if there are any improvements in the company's ability to generate profits from its assets. Additional analysis, such as comparing the ROA to industry peers or benchmarking against historical data, can provide further insights into the company's financial performance and efficiency.


Peer comparison

Dec 31, 2023

Company name
Symbol
ROA
Laboratory Corporation of America Holdings
LH
2.50%
Fulgent Genetics Inc
FLGT
-13.59%
Quest Diagnostics Incorporated
DGX
6.09%
RadNet Inc
RDNT
0.11%